Kalos Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-127
| Closed | -$10.6K | – | 117 |
|
2023
Q2 | $10.6K | Hold |
127
| – | – | 0.02% | 99 |
|
2023
Q1 | $9.68K | Hold |
127
| – | – | 0.02% | 213 |
|
2022
Q4 | $10.5K | Buy |
+127
| New | +$10.5K | 0.02% | 93 |
|
2022
Q1 | – | Sell |
-2,880
| Closed | -$374K | – | 306 |
|
2021
Q4 | $374K | Buy |
2,880
+83
| +3% | +$10.8K | 0.1% | 191 |
|
2021
Q3 | $364K | Buy |
2,797
+309
| +12% | +$40.2K | 0.1% | 186 |
|
2021
Q2 | $317K | Buy |
2,488
+69
| +3% | +$8.79K | 0.13% | 185 |
|
2021
Q1 | $302K | Sell |
2,419
-302
| -11% | -$37.7K | 0.09% | 222 |
|
2020
Q4 | $460K | Sell |
2,721
-709
| -21% | -$120K | 0.2% | 139 |
|
2020
Q3 | $417K | Sell |
3,430
-154
| -4% | -$18.7K | 0.19% | 147 |
|
2020
Q2 | $392K | Sell |
3,584
-184
| -5% | -$20.1K | 0.17% | 135 |
|
2020
Q1 | $388K | Sell |
3,768
-808
| -18% | -$83.2K | 0.17% | 133 |
|
2019
Q4 | $435K | Sell |
4,576
-210
| -4% | -$20K | 0.16% | 136 |
|
2019
Q3 | $366K | Buy |
4,786
+12
| +0.3% | +$918 | 0.15% | 136 |
|
2019
Q2 | $346K | Buy |
4,774
+1,452
| +44% | +$105K | 0.16% | 142 |
|
2019
Q1 | $300K | Sell |
3,322
-1,348
| -29% | -$122K | 0.19% | 112 |
|
2018
Q4 | $338K | Buy |
4,670
+458
| +11% | +$33.1K | 0.16% | 127 |
|
2018
Q3 | $403K | Sell |
4,212
-34
| -0.8% | -$3.25K | 0.22% | 108 |
|
2018
Q2 | $403K | Buy |
+4,246
| New | +$403K | 0.18% | 134 |
|
2018
Q1 | – | Sell |
-4,490
| Closed | -$381K | – | 219 |
|
2017
Q4 | $381K | Buy |
4,490
+96
| +2% | +$8.15K | 0.18% | 142 |
|
2017
Q3 | $380K | Sell |
4,394
-1,830
| -29% | -$158K | 0.24% | 111 |
|
2017
Q2 | $480K | Sell |
6,224
-298
| -5% | -$23K | 0.44% | 73 |
|
2017
Q1 | $452K | Sell |
6,522
-215
| -3% | -$14.9K | 0.32% | 82 |
|
2016
Q4 | $399K | Sell |
6,737
-215
| -3% | -$12.7K | 0.32% | 84 |
|
2016
Q3 | $461K | Sell |
6,952
-14
| -0.2% | -$928 | 0.39% | 78 |
|
2016
Q2 | $377K | Sell |
6,966
-1,680
| -19% | -$90.9K | 0.29% | 106 |
|
2016
Q1 | $603K | Buy |
8,646
+194
| +2% | +$13.5K | 0.5% | 66 |
|
2015
Q4 | $605K | Buy |
+8,452
| New | +$605K | 0.45% | 68 |
|